Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1996 1
1997 7
1998 1
1999 5
2001 4
2002 9
2003 9
2004 9
2005 16
2006 9
2007 29
2008 20
2009 24
2010 13
2011 17
2012 14
2013 13
2014 14
2015 10
2016 8
2017 5
2018 5
2019 3
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21060125

241 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus.
Lee NJ, Norris SL, Thakurta S. Lee NJ, et al. Ann Fam Med. 2010 Nov-Dec;8(6):542-9. doi: 10.1370/afm.1174. Ann Fam Med. 2010. PMID: 21060125 Free PMC article. Review.
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG. Ratner RE, et al. Diabet Med. 2004 Nov;21(11):1204-12. doi: 10.1111/j.1464-5491.2004.01319.x. Diabet Med. 2004. PMID: 15498087 Clinical Trial.
Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
Herrmann K, Frias JP, Edelman SV, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG. Herrmann K, et al. Postgrad Med. 2013 May;125(3):136-44. doi: 10.3810/pgm.2013.05.2635. Postgrad Med. 2013. PMID: 23748514 Clinical Trial.
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
Singh-Franco D, Robles G, Gazze D. Singh-Franco D, et al. Clin Ther. 2007 Apr;29(4):535-62. doi: 10.1016/j.clinthera.2007.04.005. Clin Ther. 2007. PMID: 17617279 Review.
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Ryan GJ, Jobe LJ, Martin R. Ryan GJ, et al. Clin Ther. 2005 Oct;27(10):1500-12. doi: 10.1016/j.clinthera.2005.10.009. Clin Ther. 2005. PMID: 16330288 Review.
Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.
Riddle M, Frias J, Zhang B, Maier H, Brown C, Lutz K, Kolterman O. Riddle M, et al. Diabetes Care. 2007 Nov;30(11):2794-9. doi: 10.2337/dc07-0589. Epub 2007 Aug 13. Diabetes Care. 2007. PMID: 17698615 Clinical Trial.
Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.
Rubin RR, Peyrot M. Rubin RR, et al. Curr Med Res Opin. 2007 Aug;23(8):1919-29. doi: 10.1185/030079907X210804. Curr Med Res Opin. 2007. PMID: 17624233
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME. Barnett AH, et al. Clin Ther. 2007 Nov;29(11):2333-48. doi: 10.1016/j.clinthera.2007.11.006. Clin Ther. 2007. PMID: 18158075 Clinical Trial.
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.
Ratner R, Whitehouse F, Fineman MS, Strobel S, Shen L, Maggs DG, Kolterman OG, Weyer C. Ratner R, et al. Exp Clin Endocrinol Diabetes. 2005 Apr;113(4):199-204. doi: 10.1055/s-2005-837662. Exp Clin Endocrinol Diabetes. 2005. PMID: 15891954 Clinical Trial.
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Whitehouse F, Kruger DF, Fineman M, Shen L, Ruggles JA, Maggs DG, Weyer C, Kolterman OG. Whitehouse F, et al. Diabetes Care. 2002 Apr;25(4):724-30. doi: 10.2337/diacare.25.4.724. Diabetes Care. 2002. PMID: 11919132 Clinical Trial.
241 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback